Rapport Therapeutics
RAPP
Last Price
52 Week Range
$7.73 - $42.27
Next Earnings Date
May 14 2026 (Estimate)
Next Earnings Date
May 14 2026 (Est.)
Last Price
Rapport Therapeutics SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Rapport Therapeutics, Inc. | S3ASR | March 10, 2026 | |
Rapport Therapeutics, Inc. | 8-K | March 10, 2026 | |
Rapport Therapeutics, Inc. | 10-K | March 10, 2026 | |
Rapport Therapeutics, Inc. | 8-K | January 7, 2026 | |
Rapport Therapeutics, Inc. | 8-K | January 7, 2026 | |
Rapport Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Rapport Therapeutics, Inc. | 8-K | November 6, 2025 | |
Rapport Therapeutics, Inc. | 8-K | September 10, 2025 | |
Rapport Therapeutics, Inc. | 8-K | September 8, 2025 | |
Rapport Therapeutics, Inc. | 8-K | September 8, 2025 | |
Rapport Therapeutics, Inc. | 8-K | August 7, 2025 | |
Rapport Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Rapport Therapeutics, Inc. | 8-K | June 18, 2025 | |
Rapport Therapeutics, Inc. | 8-K | June 2, 2025 | |
Rapport Therapeutics, Inc. | 8-K | May 8, 2025 | |
Rapport Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Rapport Therapeutics, Inc. | DEF 14A | April 24, 2025 | |
Rapport Therapeutics, Inc. | DEFA14A | April 24, 2025 | |
Rapport Therapeutics, Inc. | ARS | April 24, 2025 | |
Rapport Therapeutics, Inc. | 8-K | March 11, 2025 | |
Rapport Therapeutics, Inc. | 10-K | March 11, 2025 | |
Rapport Therapeutics, Inc. | 8-K | March 3, 2025 | |
Rapport Therapeutics, Inc. | 8-K | January 10, 2025 | |
Rapport Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Rapport Therapeutics, Inc. | 8-K | November 7, 2024 | |
Rapport Therapeutics, Inc. | 8-K | August 8, 2024 | |
Rapport Therapeutics, Inc. | 10-Q | August 8, 2024 | |
Rapport Therapeutics, Inc. | 8-K | June 10, 2024 |
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.